ScholarLens Back to search
2010•Clinical MedicineRequires access

Effects of HEAG regimen on patients with refractory/recurrent acute leukemia

Guan Jianmi

Open publisher page 0 citations

Abstract

Objective To explore the therapeutic protocol for patients with refractory/recurrent acute leukemia.MethodsTwenty-three cases of refractory acute leukemia were treated with HEAG regimen,which consisted of Hht 1-2 mg/(m2·d)(d1～14),Ara-C 30 mg/(m2·d)(d1～14),G-CSF 150 mg/(m2·d)(d1～14),and VP-16 50 ～100 mg/(m2·d)(d1～4).ResultsTwelve patients(52.2%)achieved complete remission,2 patients(8.7%)did partialremission,overan effective rate was 60.8%.ConclusionHEAG regimen in treatment of refractory/recurrent acute leukemia is an effective means.

About this research paper

What this paper is about

Objective To explore the therapeutic protocol for patients with refractory/recurrent acute leukemia.MethodsTwenty-three cases of refractory acute leukemia were treated with HEAG regimen,which consisted of Hht 1-2 mg/(m2·d)(d1～14),Ara-C 30 mg/(m2·d)(d1～14),G-CSF 150 mg/(m2·d)(d1～14),and VP-16 50 ～100 mg/(m2·d)(d1～4).ResultsTwelve patients(52.2%)achieved complete remission,2 patients(8.7%)did partialremission,overan effective rate was 60.8%.ConclusionHEAG regimen in treatment of refractory/recurrent acute leukemia is an effective means.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore the therapeutic protocol for patients with refractory/recurrent acute leukemia.MethodsTwenty-three cases of refractory acute leukemia were treated with HEAG regimen,which consisted of Hht 1-2 mg/(m2·d)(d1～14),Ara-C 30 mg/(m2·d)(d1～14),G-CSF 150 mg/(m2·d)(d1～14),and VP-16 50 ～100 mg/(m2·d)(d1～4).ResultsTwelve patients(52.2%)achieved complete remission,2 patients(8.7%)did partialremission,overan effective rate was 60.8%.ConclusionHEAG regimen in treatment of refractory/recurrent acute leukemia is an effective means.

Key concepts: Medicine, Refractory (planetary science), Regimen, Acute leukemia, Internal medicine, Leukemia, Gastroenterology, Complete remission

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Effects of HEAG regimen on patients with refractory/recurrent acute leukemia — Research Paper | ScholarLens